New York State Medicaid Evidence Based Benefit Review Advisory Committee

Webcast Link
  • Agenda is also available in Portable Document Format (PDF)
Thursday, April 10, 2025
10:00 a.m. - 3:30 p.m. (ET)

90 Church Street, New York, NY 10007 - Meeting Room 4AB


Agenda Items

The New York State Department of Health (the Department) has requested that the EBBRAC review the current scientific evidence on the topics listed below and make a recommendation regarding Medicaid coverage of the proposed technology or service:

  • Contingency Management for Stimulant Use Disorder

Proposed Agenda

(subject to change based on meeting proceedings)

10:00 - 10:10 a.m. Welcome and Introductions
10:10 - 10:40 a.m. Department of Health Updates
10:40 a.m. - 10:50 a.m. Public Comments
  • Contingency Management for Stimulant Use Disorder
10:50 a.m. - 12:00 p.m. Contingency Management for Stimulant Use Disorder
  • Evidence Review
12:00 pm. - 1:00 p.m. Lunch Break
1:00 - 2:30 p.m. Contingency Management for Stimulant Use Disorder
  • Evidence Review
  • Committee Discussion
2:30 - 3:30 p.m. Final Comments and Adjournment

Public Comments

Public comments are in person only and limited to the topics on the agenda. Comments are limited to two (2) minutes and the total public comments period will not exceed seventy-five (75) minutes.

The Department reserves the right to limit the number of interested parties providing public comments to meet timelines and accomplish meeting objectives.

Interested parties must notify the Department by April 4, 2025, of their request to address the EBBRAC in person during the public comments period. Requests may be submitted via e-mail to EBBRAC@health.ny.gov. Please include "EBBRAC Speaker Request" in the subject line of your email and attach the completed registration form found here.

All parties wishing to comment must provide a written statement summarizing the key points. Written statements must be received in an electronic format by April 4, 2025. Written statements should summarize key points and may not exceed two (2) pages in length.